Royalty Pharma (RPRX)
(Delayed Data from NSDQ)
$26.77 USD
+0.04 (0.15%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $26.76 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Industry / Sector Report
Industry : Financial - Miscellaneous Services
Zacks Industry Rank
Top 36% (89 out of 250)Zacks Sector Rank
Bottom 44% (9 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.50 | 1.69 | 9.99 |
Current Quarter Estimate | 0.93 | 7.09 | 61.00 |
Year Ago Quarter Estimate | 0.85 | 4.55 | 54.84 |
Next Quarter Estimate | 0.91 | 6.89 | 63.00 |
Next Year Estimate | 4.37 | 34.78 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -10.02 | 11.50 | 15.67 |
Next Year | 8.17 | 15.00 | 9.31 |
Last 5 Years | NA | 4.70 | 8.10 |
Next 5 Years | 1.90 | 20.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 7.10 | 13.52 |
Price/Book (MRQ) | 1.62 | 1.01 |
Price/Cash Flow (MRFY) | 5.86 | 8.14 |
Dividend Yield | 3.14% | 0.00% |
Net Profit Margin (TTM) | 35.70% | 35.58% |
Return on Equity (TTM) | 22.94% | 9.50% |
Debt to Equity (MRQ) | NA | 52.44 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.